Eric Pottier

Nessuna posizione attualmente

Commercial Services

Consumer Services

Health Technology

Profilo

Eric Pottier worked as a Plant Manager at Eurand SpA.
He then worked as the Chief Pharmacist & Vice President-Supply Chain at Sangamo Therapeutics France SAS from 2014 to 2016.
Dr. Pottier holds a doctorate degree from L'Université d'Angers.

Precedenti posizioni note di Eric Pottier

Società	Posizione	Fine
TXCELL	Direttore operativo	01/01/2014
Eurand SpA Eurand SpA Pharmaceuticals: MajorHealth Technology Eurand SpA is a specialty pharmaceutical company that develops, manufactures, and commercializes enhanced pharmaceutical and biopharmaceutical products based on its proprietary drug formulation technologies. With integrated manufacturing and R&D facilities in the U.S. and Europe, the company has partnered with pharmaceutical companies licensing its four primary technology platforms: Customized Drug Release, Bioavailability Enhancement, Taste Masking or Oral Disintegrating Tablets, and Drug Conjugation. The company is headquartered in Pessano con Bornago, Italy.	Corporate Officer/Principal	-

Vedi nel dettaglio l'esperienza di Eric Pottier

Formazione di Eric Pottier

L'Université d'Angers

Doctorate Degree

Esperienze
Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private

Vedi nel dettaglio l'esperienza di Eric Pottier

Relazioni

Relazioni di 1° grado

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Vedi i contatti personali

Società collegate

Aziende private	2
Sangamo Therapeutics France SAS Sangamo Therapeutics France SAS Miscellaneous Commercial ServicesCommercial Services Sangamo Therapeutics France SAS is a biotechnology company, which engages in developing platforms for T cell immunotherapies for the treatment of severe inflammatory and autoimmune diseases. The company was founded on April 12, 2001, and is headquartered in Valbonne-Sophia Antipolis, France.	Commercial Services
Eurand SpA Eurand SpA Pharmaceuticals: MajorHealth Technology Eurand SpA is a specialty pharmaceutical company that develops, manufactures, and commercializes enhanced pharmaceutical and biopharmaceutical products based on its proprietary drug formulation technologies. With integrated manufacturing and R&D facilities in the U.S. and Europe, the company has partnered with pharmaceutical companies licensing its four primary technology platforms: Customized Drug Release, Bioavailability Enhancement, Taste Masking or Oral Disintegrating Tablets, and Drug Conjugation. The company is headquartered in Pessano con Bornago, Italy.	Health Technology